Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Caron

Showing results (171-180 of 247) with videos related to

Pageof 25
Sort By:
Human Reproduction (Oxford, England)|April 15, 2011
Reproductive status in adult male long-term survivors of childhood cancerK Tromp, J J M Claessens, S L Knijnenburg, et al.
The Journal of Molecular Diagnostics : JMD|January 19, 2012
Stability of PCR targets for monitoring minimal residual disease in neuroblastomaJanine Stutterheim, Lily Zappeij-Kannegieter, Ingrid Ora, et al.
Clinical Chemistry|May 23, 2009
Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markersJanine Stutterheim, Annemieke Gerritsen, Lily Zappeij-Kannegieter, et al.
Oncogene|April 18, 2002
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2Marc B Godfried, Monique Veenstra, Peter v Sluis, et al.
Molecular Cancer Therapeutics|June 10, 2021
International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with CancerGilles Vassal, Peter J Houghton, Stefan M Pfister, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2017
Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patientsK C J M Kraal, G M Bleeker, B L F van Eck-Smit, et al.
Thorax|August 2, 2011
Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancerRenée L Mulder, Nienke M Thönissen, Helena J H van der Pal, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2016
Neurofeedback ineffective in paediatric brain tumour survivors: Results of a double-blind randomised placebo-controlled trialMarieke Anna de Ruiter, Jaap Oosterlaan, Antoinette Yvonne Narda Schouten-van Meeteren, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2020
Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancersNil A Schubert, Caitlin D Lowery, Guillaume Bergthold, et al.
Pediatric Blood & Cancer|January 3, 2013
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupLeontien C M Kremer, Renée L Mulder, Kevin C Oeffinger, et al.
Pageof 25

Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Human Reproduction (Oxford, England)|April 15, 2011
Reproductive status in adult male long-term survivors of childhood cancerK Tromp, J J M Claessens, S L Knijnenburg, et al.
The Journal of Molecular Diagnostics : JMD|January 19, 2012
Stability of PCR targets for monitoring minimal residual disease in neuroblastomaJanine Stutterheim, Lily Zappeij-Kannegieter, Ingrid Ora, et al.
Clinical Chemistry|May 23, 2009
Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markersJanine Stutterheim, Annemieke Gerritsen, Lily Zappeij-Kannegieter, et al.
Oncogene|April 18, 2002
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2Marc B Godfried, Monique Veenstra, Peter v Sluis, et al.
Molecular Cancer Therapeutics|June 10, 2021
International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with CancerGilles Vassal, Peter J Houghton, Stefan M Pfister, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2017
Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patientsK C J M Kraal, G M Bleeker, B L F van Eck-Smit, et al.
Thorax|August 2, 2011
Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancerRenée L Mulder, Nienke M Thönissen, Helena J H van der Pal, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2016
Neurofeedback ineffective in paediatric brain tumour survivors: Results of a double-blind randomised placebo-controlled trialMarieke Anna de Ruiter, Jaap Oosterlaan, Antoinette Yvonne Narda Schouten-van Meeteren, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2020
Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancersNil A Schubert, Caitlin D Lowery, Guillaume Bergthold, et al.
Pediatric Blood & Cancer|January 3, 2013
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupLeontien C M Kremer, Renée L Mulder, Kevin C Oeffinger, et al.
Pageof 25